Loading news...
Hope Bancorp (NASDAQ: HOPE - Get Free Report) and Avidbank (OTCMKTS:AVBH - Get Free Report) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk and dividends. Earnings and Valuation This table compares Hope Bancorp
LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (NASDAQ: HOPE) (the “Company”), the holding company of Bank of Hope (the “Bank”), today announced that Scott Yoon-Suk Whang has elected not to stand for re-election and will be retiring from his position as a member of the Boards of Directors of the Company and the Bank in connection with the Company's 2026 Annual Meeting of Stockholders. “On behalf of the Board, I would like to thank Director Whang for his many years of service and dedication,”.
LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (“the Company”) (NASDAQ: HOPE) today announced that the Company will report financial results for its fourth quarter and full year ended December 31, 2025, before the markets open on Tuesday, January 27, 2026. A conference call to discuss financial results for the fourth quarter and full year ended December 31, 2025, will be held on Tuesday, January 27, 2026, at 9:30 a.m. Pacific Time / 12:30 p.m. Eastern Time. A presentation deck to accompany th.
City Bank (OTCMKTS:CTBK - Get Free Report) and Hope Bancorp (NASDAQ: HOPE - Get Free Report) are both finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends. Valuation and Earnings This table compares City Bank
Frontier Capital Management Co. LLC lessened its holdings in shares of Hope Bancorp, Inc. (NASDAQ: HOPE) by 2.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,851,816 shares of the financial services provider's stock after selling 78,217 shares during the period.
Hope Bancorp (HOPE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Capricor Therapeutics maintains a "Hold" rating despite positive phase 3 HOPE-3 results for Deramiocel in DMD cardiomyopathy. HOPE-3 met both primary [PUL v2.0] and key secondary [LVEF] endpoints, aligning with FDA's requirements for potential BLA resubmission of Deramiocel. Regulatory uncertainty remains, particularly regarding CMC issues and whether or not HOPE-3 fully satisfies FDA approval criteria.
MIAMI--(BUSINESS WIRE)--Today, the National Cryptocurrency Association (NCA), Coinbase, and Operation HOPE announced a landmark partnership to develop and distribute free, trustworthy, and accessible crypto literacy resources to underserved communities across the United States. The effort aims to close the crypto knowledge gap and help people uplift and upskill with hands-on, safety-first education–particularly those historically underserved by traditional financial systems. A Partnership Desig.
Ensign Peak Advisors Inc trimmed its position in shares of Hope Bancorp, Inc. (NASDAQ: HOPE) by 23.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 56,143 shares of the financial services provider's stock after selling 17,500 shares during the period. Ensign Peak Advisors
The S&P 600 Small/MidCap index offers high-yield dividend opportunities, with 33 out of 53 top-yielding stocks meeting both the 'safer' and IDEAL dividend Dogcatcher criteria. Top ten S&P600 dividend 'dogs' are projected to deliver 24% to 93% net gains by November 2026, based on analyst targets and current yields. Stocks like KNTK, SM, CRGY, and DEI stand out for strong total return potential, but investors should beware of negative free cash flow in some high-yield picks.
SARASOTA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- HOPE Therapeutics™, Inc. ("HOPE"), an interventional psychiatry network owned by NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) today announced initiation of patient care with for treatment-resistant depression with the Ampa one day (ONE-D) protocol. HOPE is the first to deploy the Ampa technology in Florida and one of the first deployments nationwide. The Ampa device differs from other Transcranial Magnetic Stimulation (TMS) treatments in that the peer-reviewed literature has reported a high rate of success (87% response and 72% remission) in nonrandomized trials when a single day of TMS treatment is combined with physician-prescribed D-cycloserine and lisdexamfetamine (note that neither of the drugs reported in the published results is FDA-approved for the stated indication).1 D-cycloserine was previously reported to substantially enhance the effectiveness of TMS in reducing depression and suicidality by more than two-fold in a placebo-controlled trial using a traditional TMS protocol.2 Additional supportive findings documenting the effect of D-cycloserine in enhancing the effect of TMS were recently published by a team of researchers led by Prof. Joshua Brown at Harvard's McLean hospital.3 Dr. Brown additionally serves as the President of the Clinical TMS Society.
Mutual of America Capital Management LLC lowered its position in Hope Bancorp, Inc. (NASDAQ: HOPE) by 7.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,286 shares of the financial services provider's stock after selling 1,299 shares
Hope Bancorp reported mixed Q3 results, with top-line beats but bottom-line misses, and improving asset quality and net interest margins (NIMs). Loan and deposit growth for HOPE remains sluggish, mainly due to California's economic slowdown, but management is expanding into new markets and hiring talent to drive growth. NIMs expanded significantly from 2.54% to 2.89% due to merger synergies and asset redeployment but are expected to stabilize as these benefits normalize.
Hope Bancorp, Inc. (NASDAQ:HOPE ) Q3 2025 Earnings Call October 28, 2025 12:30 PM EDT Company Participants Maxime Olivan Kevin Kim - Chairman, President & CEO Julianna Balicka - Executive VP & CFO Peter Koh - Senior EVP & COO Conference Call Participants Matthew Clark - Piper Sandler & Co., Research Division Gary Tenner - D.A. Davidson & Co., Research Division Kelly Motta - Keefe, Bruyette, & Woods, Inc., Research Division Timothy Coffey - Janney Montgomery Scott LLC, Research Division Presentation Operator Good day, and welcome to the Hope Bancorp 2025 Third Quarter Earnings Conference Call.
Although the revenue and EPS for Hope Bancorp (HOPE) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Hope Bancorp (HOPE) came out with quarterly earnings of $0.25 per share, missing the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.21 per share a year ago.
LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (the “Company”) (NASDAQ: HOPE) today announced that its Board of Directors declared a quarterly cash dividend of $0.14 per common share. The dividend is payable on or about November 21, 2025, to all stockholders of record as of the close of business on November 7, 2025. About Hope Bancorp, Inc. Hope Bancorp, Inc. (NASDAQ: HOPE) is the holding company of Bank of Hope, the only regional Korean American bank in the United States with $18.51 billion.
LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (the “Company”) (NASDAQ: HOPE), the holding company of Bank of Hope (the “Bank”), today reported unaudited financial results for its third quarter ended September 30, 2025. For the three months ended September 30, 2025, the Company recorded net income of $30.8 million, or $0.24 per diluted common share, up 28% from net income of $24.2 million, or $0.20 per diluted share, for the three months ended September 30, 2024, and up from a net loss of $27.
Hope Bancorp (NASDAQ: HOPE - Get Free Report) will likely be releasing its Q3 2025 results before the market opens on Tuesday, October 28th. Analysts expect the company to announce earnings of $0.26 per share and revenue of $138.8670 million for the quarter. Individuals can check the company's upcoming Q3 2025 earningsummary page for the latest
LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (NASDAQ: HOPE) today announced that the Company will report financial results for its third quarter and nine months ended September 30, 2025, before the markets open on Tuesday, October 28, 2025. A conference call to discuss 2025 third quarter financial results will be held on Tuesday, October 28, 2025, at 9:30 a.m. Pacific Time / 12:30 p.m. Eastern Time. A presentation deck to accompany the earnings call will be available at Hope Bancorp's inves.